Correlation Between ICD and RPBio
Can any of the company-specific risk be diversified away by investing in both ICD and RPBio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ICD and RPBio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ICD Co and RPBio Inc, you can compare the effects of market volatilities on ICD and RPBio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ICD with a short position of RPBio. Check out your portfolio center. Please also check ongoing floating volatility patterns of ICD and RPBio.
Diversification Opportunities for ICD and RPBio
Good diversification
The 3 months correlation between ICD and RPBio is -0.13. Overlapping area represents the amount of risk that can be diversified away by holding ICD Co and RPBio Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on RPBio Inc and ICD is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ICD Co are associated (or correlated) with RPBio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of RPBio Inc has no effect on the direction of ICD i.e., ICD and RPBio go up and down completely randomly.
Pair Corralation between ICD and RPBio
Assuming the 90 days trading horizon ICD is expected to generate 1.2 times less return on investment than RPBio. In addition to that, ICD is 2.03 times more volatile than RPBio Inc. It trades about 0.04 of its total potential returns per unit of risk. RPBio Inc is currently generating about 0.09 per unit of volatility. If you would invest 505,000 in RPBio Inc on December 30, 2024 and sell it today you would earn a total of 67,000 from holding RPBio Inc or generate 13.27% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
ICD Co vs. RPBio Inc
Performance |
Timeline |
ICD Co |
RPBio Inc |
ICD and RPBio Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with ICD and RPBio
The main advantage of trading using opposite ICD and RPBio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ICD position performs unexpectedly, RPBio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in RPBio will offset losses from the drop in RPBio's long position.ICD vs. SFA Engineering | ICD vs. APS Holdings | ICD vs. Soulbrain Holdings Co | ICD vs. JUSUNG ENGINEERING Co |
RPBio vs. NH Investment Securities | RPBio vs. Iljin Display | RPBio vs. Sangsin Energy Display | RPBio vs. Daelim Trading Co |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Other Complementary Tools
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |